Market Overview

Galena Biopharma Announces Public Offering of Common Stock


Galena Biopharma (Nasdaq: GALE) announced today that it intends to offer shares of its common stock in an underwritten public offering. Roth Capital Partners, LLC is acting as the sole book-running manager for the offering.

Posted-In: News Offerings


Related Articles (GALE)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→